Skip to content

Author

Soumyajit Roy

We have 4 of 18 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Metastasis-directed radiotherapy (MDRT) for men with de novo, oligometastatic prostate cancer treated with long-term androgen deprivation therapy in the STAMPEDE trial (METANOVA): protocol for a multicentre, phase II randomised controlled trial in the USA

Abstract Introduction Prostate cancer (PCa) is the most commonly diagnosed cancer in men worldwide. A rising proportion of men present with de novo metastatic disease, a state associated with poor survival outcomes and limited curative treatment options. Within this group, a subset of patients exhibit oligometastatic d...

S. Lichtman-Mikol, J. Lang, H. Nagar et al. · 1 citation
Review Open access Sep 2026

Cardiovascular Risk Triage Schema for Patients With Prostate Cancer Treated With Hormone Therapy.

IMPORTANCE Cardiovascular disease (CVD) is a leading noncancer cause of death among patients with prostate cancer (PC). Population-based risk calculators do not account for treatment-related effects of androgen-deprivation therapy (ADT) and androgen receptor pathway inhibitors (ARPis), and they have not been validated...

A. Guha, Ana Barac, M. Ryan et al. · 0 citations
Open access Sep 2026

Trends in Prebiopsy MRI Utilization for Prostate Cancer Detection.

This cohort study evaluates rates of magnetic resonance imaging (MRI) use prior to prostate biopsy in the US from January 2017 to June 2026, as support for this practice continues to increase.

Stephen Rhodes, S. Basourakos, Jim C. Hu et al. · 0 citations
Aug 2026

Prognostic and Predictive Effect of Age in Molecularly Defined Lower-Grade Gliomas.

PURPOSE Age ≥40 years is regarded as a high-risk feature and an indication for adjuvant chemoradiotherapy for patients with lower-grade glioma in clinical practice guidelines. It is unclear whether age remains a relevant prognostic factor for contemporary definitions of lower-grade gliomas in the molecular era. METHO...

C. Kinslow, G. Minniti, P. Brown et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.